自动细胞影像系统市场规模、份额及成长分析（按产品/服务、应用、技术、最终用户和地区）－2025 年至 2032 年产业预测

自动化细胞成像系统市场规模预计在 2023 年达到 1,274.8 亿美元，并将从 2024 年的 1,379.3 亿美元成长到 2032 年的 2,591.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.2%。

受全球慢性病盛行率上升以及药物和疫苗研发投资增加的推动，自动化细胞成像系统市场预计将强劲成长。然而，维护成本高、备件有限等挑战可能会阻碍市场扩张。目前，北美凭藉其早期采用的先进医疗保健技术占据市场主导地位，而美国在该领域处于领先地位。与此同时，亚太地区在医疗基础设施大量投资的推动下正在经历快速成长。总体而言，成长机会充满希望，但重要的是解决现有的挑战以维持自动化细胞成像系统市场的发展势头。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

自动细胞影像系统市场规模（依产品/服务及复合年增长率）(2025-2032)

• 市场概览
• 装置
• 耗材
• 软体
• 服务

自动细胞成像系统市场规模（按应用和复合年增长率） (2025-2032)

• 市场概览
• 药物研发
• 诊断
• 生物和生物医学研究
• 其他用途

自动细胞影像系统市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 萤光影像
• 明场影像
• 高内涵筛检
• 其他技术

自动细胞成像系统市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 製药和生物技术公司
• 学术研究所
• 医院
• 诊断实验室
• 其他最终用户

自动细胞影像系统市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• General Electric Company（USA）
• Olympus Corporation（Japan）
• PerkinElmer Inc.（USA）
• Sartorius AG（Germany）
• Thermo Fisher Scientific Inc.（USA）
• West Medica（Austria）
• Norma Diagnostika GmbH（Germany）
• BioView Ltd.（Israel）
• Caliber ID（USA）
• Molecular Devices, LLC（USA）
• Nikon Corporation（Japan）
• Leica Microsystems GmbH（Germany）
• Carl Zeiss AG（Germany）
• Agilent Technologies, Inc.（USA）
• Becton, Dickinson and Company（USA）
• Merck KGaA（Germany）
• Tecan Group Ltd.（Switzerland）
• Danaher Corporation（USA）

结论和建议

Automated Cell Imaging System Market size was valued at USD 127.48 billion in 2023 and is poised to grow from USD 137.93 billion in 2024 to USD 259.11 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).

The market for automated cell imaging systems is poised for robust growth, fueled by rising chronic disease prevalence globally and increased investment in drug and vaccine research and development. However, challenges such as high maintenance costs and limited spare parts availability may hinder market expansion. North America currently dominates the market, driven by early adoption of advanced healthcare technologies, with the USA leading in this sector. Meanwhile, the Asia-Pacific region is experiencing rapid growth, attributed to significant investments in healthcare infrastructure. Overall, while opportunities for growth are promising, addressing the existing challenges will be crucial to sustaining momentum in the automated cell imaging system market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Automated Cell Imaging System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Automated Cell Imaging System Market Segments Analysis

Global Automated Cell Imaging System Market is segmented by Product, Application, Technology, End User and region. Based on Product, the market is segmented into Instruments, Consumables, Software and Services. Based on Application, the market is segmented into Drug Discovery, Diagnostics, Biological and Biomedical Research and Other Applications. Based on Technology, the market is segmented into Fluorescence Imaging, Brightfield Imaging, High-Content Screening and Other Technologies. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals, Diagnostic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Automated Cell Imaging System Market

The Automated Cell Imaging System market is significantly driven by the rising incidence of genetic deformities caused by lifestyle changes and radiation exposure, which can lead to irregular cell division and tumor development. Additionally, contamination of water, food, and soil with certain chemicals contributes to cancer prevalence. The emergence of new cancer types necessitates advanced imaging technologies to study the dynamics and functions of telomeric repeat-containing RNA, underscoring the importance of automated cell imaging systems. These systems have become essential tools in cellular research, enabling scientists to analyze digital microscopic images of cancerous cells with precision and efficiency, thereby propelling market growth.

Restraints in the Automated Cell Imaging System Market

The Automated Cell Imaging System market faces significant restraints due to the high costs associated with both spare parts and initial setup. When components of these systems become damaged, they often need to be fully replaced, leading to substantial expenses, exacerbated by the limited number of manufacturers available, which creates a supply deficit. Additionally, the initial investment necessary to establish such systems can be quite steep, coupled with the requirement for considerable electricity to operate them. These factors combined present notable challenges for market growth and limit accessibility for many potential users.

Market Trends of the Automated Cell Imaging System Market

The Automated Cell Imaging System market is witnessing significant growth driven by a surge in research and development of new drugs, as major pharmaceutical companies increasingly invest in advanced technologies. This trend is fueled by the need for high-throughput screening and precise analysis in drug discovery, as these systems minimize human error and reduce the time required for interventions in lengthy experiments involving extensive chemical libraries. By acquiring and analyzing high-resolution images, automated cell imaging systems enhance the efficiency and accuracy of research processes, thereby accelerating the development of innovative vaccines and therapeutics and positioning themselves as indispensable tools in modern biomedical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Automated Cell Imaging System Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables
• Software
• Services

Global Automated Cell Imaging System Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Diagnostics
• Biological and Biomedical Research
• Other Applications

Global Automated Cell Imaging System Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Fluorescence Imaging
• Brightfield Imaging
• High-Content Screening
• Other Technologies

Global Automated Cell Imaging System Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals
• Diagnostic Laboratories
• Other End Users

Global Automated Cell Imaging System Market Size & CAGR (2025-2032)

• North America (Product & Service, Application, Technology, End User)
  • US
  • Canada
• Europe (Product & Service, Application, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• General Electric Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Medica (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norma Diagnostika GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioView Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caliber I.D. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Microsystems GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations